Guidelines by American College of Cardiology, American Heart Association & other organisations endorse early detection and treatment of dyslipidemia—unhealthy levels of fats in blood.
Set to enter larger trial across 5 countries, it works by permanently turning off gene that causes high bad cholesterol levels. Commonly used drugs work by inhibiting cholesterol-causing enzyme.
It is still in initial stages & could eventually be integrated with mobile phones, enabling patients to monitor blood health on the go. Clinical trials conducted with around 50 patients.
For the first time, the guidelines are aimed at clinicians, individuals and medical laboratories. The cut-off for various lipid markers was modified based on risk factors.
Novartis India, the company that has the import and marketing permission for Inclisiran, refused to divulge the price of the drug in India, but market sources say it is going to be Rs 1.2 lakh per jab.
Study — led by Dr S. Anitha, senior scientist, nutrition, at ICRISAT — is a review and analysis of 8 previously published studies. It was published in the journal 'Nutrients' this month.
While the Russia-Ukraine war saw the BJP projecting PM Modi as a ‘vishwaguru’ who could end international conflicts, the party has made a nuanced shift in its electoral strategy vis-à-vis the West Asia war.
Report on impact of AI emergence—drawing upon depositions from several ministries—confirms that the developments come in the absence of AI laws or considerations over them.
It’s easy to understand why the government can’t speak the hard truth. When this war ends, as all wars do, India’s interests will lie with both the winner and the loser.
COMMENTS